NBC10 Boston reports on fresh research showing weight loss drugs remain the biggest factor behind growing insurance spending in the state.
Recap by typeshit. Post by @nbc10boston on Instagram.
Costco is adding Novo Nordisk's semaglutide shots to what it offers. Details are thin here, so tap through for how pricing and access will work.
An explainer on talking to a provider about whether Wegovy fits you, plus a reminder that insurance may not pay for it.
Khunti shares real-world data on over a million UK adults using telehealth for obesity care, where 90% started on tirzepatide before a major price hike changed prescribing.
Polskie Radio reports a Wegovy price cut in China, coming soon after the drug's approval there. Tap through for the details.
Dr Kopelman's office says GLP-1 drugs can work well for weight loss, but some patients report hair thinning along the way.
Texas A&M Medicine says the wider use of GLP-1 drugs is changing how people talk about body image, weight stigma and self-worth.
Loading…